Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia – an update

Author： Scharfetter Joachim  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.5, Iss.6, 2004-09, pp. : 691-698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetics of Antipsychotic Drugs in Schizophrenia Treatment

By Tybura Piotr   Trzesniowska-Drukala Beata   Samochowiec Jerzy  

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Antipsychotic Drugs in Schizophrenia Treatment

By  

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Developments in antipsychotic drugs – an update

By Reynolds G.P.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 2, 1998-02 ,pp. : 257-260

Informa Healthcare

Access to resources Recommend Favorite

Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes

By Zhang Xiang Rong   Zhang Zhi Jun   Zhu Rong Xin   Yuan Yong Gui   Jenkins Trisha A   Reynolds Gavin P  

Pharmacogenomics, Vol. 12, Iss. 8, 2011-08 ,pp. : 1127-1136

Future Medicine

Access to resources Recommend Favorite

In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles

By Assié Marie-Bernadette   Dominguez Hélène   Consul-Denjean Nathalie   Newman-Tancredi Adrian  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 6, 2006-09 ,pp. : 441-450

Springer Publishing Company

Access to resources Recommend Favorite